ARG1 and neoplasm: By immune phenotyping, we observed an upregulation in the expression of T cell-suppressive molecules, PD-L1, Fas Ligand (FasL), and ARG1 across moDC, M-MDSC, and G-MDSC subsets from day 5 to day 11 post-tumor induction (Figure 1C).